Results 181 to 190 of about 114,029 (285)

Pembrolizumab for Early‐Stage Triple‐Negative Breast Cancer: KEYNOTE‐522 Japan Subgroup Analysis

Cancer Science, EarlyView.
In the global, phase 3 KEYNOTE‐522 study of high‐risk early‐stage triple‐negative breast cancer (TNBC), neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab improved efficacy outcomes versus neoadjuvant chemotherapy alone. In this analysis of Japanese participants from KEYNOTE‐522, neoadjuvant pembrolizumab plus chemotherapy ...
Masato Takahashi, Hirofumi Mukai, Toshimi Takano, Koichiro Tsugawa, Kenichi Inoue, Mitsuya Itoh, Junichiro Watanabe, Yuko Tanabe, Naohito Yamamoto, Yasuo Miyoshi, Kenichi Watanabe, Toru Mukohara, Yibin Kong, Masashi Shimura, Francisco Beca, Peter Schmid, Hiroji Iwata   +16 more
wiley   +1 more source

The Role of Minimally Invasive Adrenalectomy for Large Adrenal Tumors (≥6 cm): Evidence from a 10-Year Retrospective Study. [PDF]

J Clin Med
Rossi L, Becucci C, Della Posta O, Papini P, Palma F, Cammarata M, Sacco L, Dekova K, Ajdini S, Ambrosini CE, Materazzi G.   +10 more
europepmc   +1 more source

Genetic Alterations in Benign Adrenal Tumors. [PDF]

Biomedicines, 2022
Pitsava G, Stratakis CA.
europepmc   +1 more source

Analysis of Peripheral T Cell Profiling and Plasma Proteomics in Advanced NSCLC Patients Treated With Atezolizumab

Cancer Science, EarlyView.
This study found immune markers that may predict how well patients with advanced lung cancer respond to atezolizumab. Higher levels of certain T cells were linked to better survival. Specific patterns suggested a worse prognosis for some patients. ABSTRACT We investigated immunologic biomarkers that predict outcomes of patients with previously treated ...
Atsuto Mouri, Hiroshi Kagamu, Koji Tamada, Makoto Nishio, Hiroaki Akamatsu, Yasushi Goto, Hidetoshi Hayashi, Satoru Miura, Akihiko Gemma, Ichiro Yoshino, Toshihiro Misumi, Ryota Saito, Noriko Yanagitani, Fujita Masaki, Hiroshi Nokihara, Kazumi Nishino, Masahiro Seike, Tetsunari Hase, Osamu Hataji, Hiroaki Takeoka, Yosuke Kawashima, Hirotaka Kuroki, Masamichi Sugimoto, Hiroshi Kuriki, Tetsuya Mitsudomi   +24 more
wiley   +1 more source

Clinicopathological spectrum of adrenal tumors: a retrospective study from a Romanian tertiary referral center. [PDF]

Rom J Morphol Embryol
Cătană RT, Nechifor-Boilă AC, Moica S, Chinezu L, Borda A.   +4 more
europepmc   +1 more source

Surgical treatment of adrenal tumors during pregnancy. [PDF]

Rev Endocr Metab Disord, 2023
Bartz-Kurycki MA, Dream S, Wang TS.
europepmc   +1 more source

Rapid sensitive and reproducible assays for human parathyrin [PDF]

, 1978
Kuflicki, G., Marschner, I., Scriba, Peter Christian, Wood, W. G.   +3 more
core   +1 more source

Refining Tumor Mutational Burden as a Predictive Biomarker for Pembrolizumab: A Real‐World Analysis in Japanese Patients

Cancer Science, EarlyView.
In this study, we investigated the predictive value of tumor mutational burden (TMB) for assessing the efficacy of pembrolizumab in a Japanese cohort. We analyzed real‐world data from 63,952 patients registered in the C‐CAT database who underwent comprehensive genomic profiling, and evaluated the therapeutic efficacy of pembrolizumab in 1899 of these ...
Tomoyo Yasuda, Mio Yumura, Azusa Hamasaki, Tongyi Fei, Takashi Kubo, Hitoshi Ichikawa, Takashi Kohno, Kuniko Sunami   +7 more
wiley   +1 more source

Adrenal Tumors in Children and Adolescents in Sweden: A Register-Based Study Covering 15 Years. [PDF]

J Endocr Soc
Terezaki E, Calissendorff J, Mannheimer B, Lindh JD, Falhammar H.   +4 more
europepmc   +1 more source

Mortality in Patients With Nonfunctional Adrenal Tumors.

JAMA Intern Med, 2023
Patrova J, Mannheimer B, Lindh JD, Falhammar H.   +3 more
europepmc   +1 more source